Alterations in amphetamine-stimulated dopamine overflow due to the Nurr1-null heterozygous genotype and postweaning isolation

Synapse

Volumn 62, Issue 10, 2008, Pages 764-774

  Moore, Talisha M ^a   Brown, Timothy ^a   Cade, Mirae ^a   Eells, Jeffrey B ^a  

^a MISSISSIPPI STATE UNIVERSITY   (United States)

Author keywords

Dopamine; Mesoaccumbens; Nigrostriatal; NR4A2; Postweaning isolation

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; AMPHETAMINE; DOPAMINE; NUCLEAR RECEPTOR RELATED FACTOR 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN DEVELOPMENT; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC TRANSMISSION; GENETIC PREDISPOSITION; GENOTYPE; HETEROZYGOSITY; MICRODIALYSIS; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; NULL ALLELE; PRIORITY JOURNAL; SCHIZOPHRENIA; WILD TYPE;

AMPHETAMINE; ANIMALS; CORPUS STRIATUM; DNA-BINDING PROTEINS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENOTYPE; HETEROZYGOTE DETECTION; MALE; MICE; MICE, KNOCKOUT; NUCLEUS ACCUMBENS; SOCIAL ISOLATION; TRANSCRIPTION FACTORS; WEANING;

EID: 50249090143     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20550     Document Type: Article

References (45)

1. Abi-Dargham A, Gil R, Krystal J, Baldwin RM, Seibyl JP, Bowers M, van Dyck CH, Charney DS, Innis RB, Laruelle M. 1998. Increased striatal dopamine transmission in schizophrenia: Confirmation in a second cohort. Am J Psychiatry 155:761-767.
2. Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, Gil R, Kegeles LS, Weiss R, Cooper TB, Mann JJ, Van Heertum RL, Gorman JM, Laruelle M. 2000. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci USA 97:8104-8109.
3. Agid O, Shapira B, Zislin J, Ritsner M, Hanin B, Murad H, Troudart T, Bloch M, Heresco-Levy U, Lerer B. 1999. Environment and vulnerability to major psychiatric illness: A case control study of early parental loss in major depression, bipolar disorder and schizophrenia. Mol Psychiatry 4:163-172.
4. Backman C, You ZB, Perlmann T, Hoffer BJ. 2003. Elevated locomotor activity without altered striatal dopamine contents in Nurr1 heterozygous mice after acute exposure to methamphetamine. Behav Brain Res 143:95-100.
5. Bannon MJ, Pruetz B, Barfield E, Schmidt CJ. 2004. Transcription factors specifying dopamine phenotype are decreased in cocaine users. Neuroreport 15:401-404.
6. Buervenich S, Carmine A, Arvidsson M, Xiang F, Zhang Z, Sydow O, Jonsson EG, Sedvall GC, Leonard S, Ross RG, Freedman R, Chowdari KV, Nimgaonkar VL, Perlmann T, Anvret M, Olson L. 2000. NURR1 mutations in cases of schizophrenia and manic-depressive disorder. Am J Med Genet 96:808-813.
7. Capuano B, Crosby IT, Lloyd EJ. 2002. Schizophrenia: Genesis, receptorology and current therapeutics. Curr Med Chem 9:521-548.
8. Castillo SO, Baffi JS, Palkovits M, Goldstein DS, Kopin IJ, Witta J, Magnuson MA, Nikodem VM. 1998a. Dopamine biosynthesis is selectively abolished in substantia nigra/ventral tegmental area but not in hypothalamic neurons in mice with targeted disruption of the Nurr1 gene. Mol Cell Neurosci 11:36-46.
9. Castillo SO, Xiao Q, Kostrouch Z, Dozin B, Nikodem VM. 1998b. A divergent role of COOH-terminal domains in Nurr1 and Nur77 transactivation. Gene Expr 7:1-12.
10. Chen YH, Tsai MT, Shaw CK, Chen CH. 2001. Mutation analysis of the human NR4A2 gene, an essential gene for midbrain dopaminergic neurogenesis, in schizophrenic patients. Am J Med Genet 105:753-757.
11. Cragg SJ, Greenfield SA. 1997. Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum. J Neurosci 17:5738-5746.
12. Day-Wilson KM, Jones DNC, Southam E, Cilia J, Totterdell S. 2006. Medial prefrontal cortex volume loss in rats with isolation rearing-induced deficits in prepulse inhibition of acoustic startle. Neuroscience 141:1113-1121.
13. Eells JB, Lipska BK, Yeung SK, Misler JA, Nikodem VM. 2002. Nurr1-null heterozygous mice have reduced mesolimbic and mesocortical dopamine levels and increased stress-induced locomotor activity. Behav Brain Res 136:267.
14. Eells JB, Misler JA, Nikodem VM. 2006a. Early postnatal isolation reduces dopamine levels, elevates dopamine turnover and specifically disrupts prepulse inhibition in Nurr1-null heterozygous mice. Neuroscience 140:1117-1126.
15. Eells JB, Misler JA, Nikodem VM. 2006b. Reduced tyrosine hydroxylase and GTP cyclohydrolase mRNA expression, tyrosine hydroxylase activity, and associated neurochemical alterations in Nurr1-null heterozygous mice. Brain Res Bull 70:186-195.
16. Fulford AJ, Marsden CA. 1998. Effect of isolation-rearing on conditioned dopamine release in vivo in the nucleus accumbens of the rat. J Neurochem 70:384-390.
17. Gil M, McKinney C, Lee M, Eells JB, Phyillaier MA, Nikodem VM. 2007. Regulation of GTP cyclohydrolase I expression by orphan receptor Nurr1 in cell culture and in vivo. J Neurochem 101:142-150.
18. Goodman LA, Salyers MP, Mueser KT, Rosenberg SD, Swartz M, Essock SM, Osher FC, Butterneid MI, Swanson J. 2001. Recent victimization in women and men with severe mental illness: Prevalence and correlates. J Trauma Stress 14:615-632.
19. Hall FS, Wilkinson LS, Humby T, Inglis W, Kendall DA, Marsden CA, Robbins TW 1998. Isolation rearing in rats: Pre- and postsynaptic changes in striatal dopaminergic systems. Pharmacol Biochem Behav 59:859-872.
20. Heidbreder CA, Foxton R, Cilia J, Hughes ZA, Shah AJ, Atkins A, Hunter AJ, Hagan JJ, Jones DN. 2001. Increased responsiveness of dopamine to atypical, but not typical antipsychotics in the medial prefrontal cortex of rats reared in isolation. Psychopharmacology (Berl) 156:338-351.
21. Holowka DW, King S, Saheb D, Pukall M, Brunet A. 2003. Childhood abuse and dissociative symptoms in adult schizophrenia. Schizophr Res 60:87-90.
22. Jiang C, Wan X, He Y, Pan T, Jankovic J, Le W. 2005. Age-dependent dopaminergic dysfunction in Nurr1 knockout mice. Exp Neurol 191:154-162.
23. Jones SR, Gainetdinov RR, Wightman RM, Caron MG. 1998. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci 18:1979-1986.
24. Kim KS, Kim CH, Hwang DY, Seo H, Chung S, Hong SJ, Lim JK, Anderson T, Isacson O. 2003. Orphan nuclear receptor Nurr1 directly transactivates the promoter activity of the tyrosine hydroxylase gene in a cell-specific manner. J Neurochem 85:622-634.
25. Le W, Conneely OM, He Y, Jankovic J, Appel SH. 1999. Reduced Nurr1 expression increases the vulnerability of mesencephalic dopamine neurons to MPTP-induced injury. J Neurochem 73:2218-2221.
26. Lieberman JA, Kinon BJ, Loebel AD. 1990. Dopaminergic mechanisms in idiopathic and drug-induced psychoses. Schizophr Bull 16:97-110.
27. Lindgren N, Xu ZQ, Herrera-Marschitz M, Haycock J, Hokfelt T, Fisone G. 2001. Dopamine D(2) receptors regulate tyrosine hydroxylase activity and phosphorylation at Ser40 in rat striatum. Eur J Neurosci 13:773-780.
28. Maheux J, Ethier I, Rouillard C, Levesque D. 2005. Induction patterns of transcription factors of the nur family (nurr1, nur77, and nor-1) by typical and atypical antipsychotics in the mouse brain: Implication for their mechanism of action. J Pharmacol Exp Ther 313:460-473. (Epub 2004 Dec 2022).
29. Marinelli M, Rudick CN, Hu XT, White FJ. 2006. Excitability of dopamine neurons: modulation and physiological consequences. CNS Neurol Disord Drug Targets 5:79-97.
30. Melendez RI, Gregory ML, Bardo MT, Kalivas PW. 2004. Impoverished rearing environment alters metabotropic glutamate receptor expression and function in the prefrontal cortex. Neuropsychopharmacology 29:1980-1987.
31. Messier C, Emond S, Ethier K. 1999. New techniques in stereotaxic surgery and anesthesia in the mouse. Pharmacol Biochem Behav 63:313-318.
32. Paxinos G, Franklin KBJ. 2000. The mouse brain in stereotaxic coordinates, deluxe,2nd ed. New York: Academic Press.
33. Pearlson GD. 2000. Neurobiology of schizophrenia. Ann Neurol 48:556-566.
34. Sacchetti P, Mitchell TR, Granneman JG, Bannon MJ. 2001. Nurr1 enhances transcription of the human dopamine transporter gene through a novel mechanism. J Neurochem 76:1565-1572.
35. Saucedo-Cardenas O, Quintana-Hau JD, Le WD, Smidt MP, Cox JJ, De Mayo F, Burbach JP, Conneely OM. 1998. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc Natl Acad Sci USA 95:4013-4018.
36. Schmitz Y, Schmauss C, Sulzer D. 2002. Altered dopamine release and uptake kinetics in mice lacking D2 receptors. J Neurosci 22:8002-8009.
37. Swanson J, Kinsbourne M, Nigg J, Lanphear B, Stefanatos G, Volkow N, Taylor E, Casey B, Castellanos F, Wadhwa P. 2007. Etiologic subtypes of attention-deficit/hyperactivity disorder: Brain imaging. Molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychology Review 17:39-59.
38. Swerdlow NR, Braff DL, Masten VL, Geyer MA. 1990. Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens. Psychopharmacology (Berl) 101:414-420.
39. Tseng KY, Roubert C, Do L, Rubinstein M, Kelly MA, Grandy DK, Low MJ, Gershanik OS, Murer MG, Giros B, Raisman-Vozari R. 2000. Selective increase of Nurr1 mRNA expression in mesencephalic dopaminergic neurons of D2 dopamine receptor-deficient mice. Brain Res Mol Brain Res 80:1-6.
40. Tzschentke TM. 2001. Pharmacology and behavioral pharmacology of the mesocortical dopamine system. Prog Neurobiol 63:241-320.
41. Ventura R, Alcaro A, Cabib S, Conversi D, Mandolesi L, Puglisi-Allegra S. 2004. Dopamine in the medial prefrontal cortex controls genotype-dependent effects of amphetamine on mesoaccumbens dopamine release and locomotion. Neuropsychopharmacology 29:72-80.
42. Wan FJ, Swerdlow NR. 1993. Intra-accumbens infusion of quinpirole impairs sensorimotor gating of acoustic startle in rats. Psychopharmacology (Berl) 113:103-109.
43. Weiss IC, Di Iorio L, Feldon J, Domeney AM. 2000. Strain differences in the isolation-induced effects on prepulse inhibition of the acoustic startle response and on locomotor activity. Behav Neurosci 114:364-373.
44. Weiss IC, Feldon J. 2001. Environmental animal models for sensorimotor gating deficiencies in schizophrenia: a review. Psychopharmacology (Berl) 156:305-326.
45. Zetterstrom RH, Solomin L, Jansson L, Hoffer BJ, Olson L, Perlmann T. 1997. Dopamine neuron agenesis in Nurr1-deficient mice. Science 276:248-250.